PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
DelveInsight

Press Release


Receive press releases from DelveInsight: By Email RSS Feeds:

Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors Pipeline Insights, 2016


DelveInsight, the leading market research and consulting company has added new report STAT3 inhibitors-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this DelveInsight’s research expertise provides the clients with up to date information of market till date order has been placed.

New Delhi, India, February 25, 2016 --(PR.com)-- The Indication pipeline Insight Reports provides client with details on STAT3 Inhibitors Pipeline products across the globe. It comprehensively includes:

· Comparative study of drugs under development.
· Information on several other drugs as well among which 1 are in phase III, 5 in phase II, 3 in phase I, 3 in pre - clinical and 6 in dormant phase.
· R&D activities and technologies used along with the pipeline molecules in development.
· Information related to collaborations, in-licensing and out-licensing deals.
· Stages of development of pipeline molecules.
· Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.

Report Coverage:
· 20+ Products, 15+ Companies

Signal Transducer And Activator Of Transcription 3 (STAT3) Inhibitors - Pipeline Insights, 2016 Report envisages Pipeline Intelligence by identifying the key players along with their potential pipeline molecule. Therefore DelveInsight’s report on STAT3 Inhibitors helps to optimize portfolio by creating effective counter-strategies to gain competitive and therapeutic advantage in global Pharma market. In addition, it assesses the major market drivers and barriers in development of Pipeline molecules which helps to understand market for collaborations and licensing deals.

DelveInsight is offering the Report at a price of US 1,250 as a single user license, USD 2,500 as a site license and USD 4,000 as a Global/Enterprise License.

For more information on Pipeline Insight Reports, email at info@delveInsight.com

About Us
DelveInsight is a leading Business Consulting and Market Research Firm. DelveInsight help the clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.
Contact Information
DelveInsight
Neelaksh Dani
+91-11-4568 9769
Contact
www.delveinsight.com

Click here to view the list of recent Press Releases from DelveInsight
Promote Your Business